Canada: Study Officially Completed
On November 27, 2016, investigators gathered for the formal closeout of our Phase 2 pilot study of MDMA-assisted psychotherapy for PTSD in Vancouver, Canada. Conducted by Clinical Trial Leader Alli Feduccia, …
Canada News Timeline
Canada: Final Participant Completes 12-Month Follow-Up
On October 17, 2016, the sixth and final participant completed their 12-month follow-up interview in our Phase 2 pilot study of MDMA-assisted psychotherapy for PTSD in Vancouver, Canada. All participants …
Canada: Enrollment Concluded
On November 2, 2015, enrollment was concluded in our study of MDMA-assisted psychotherapy for PTSD from sexual assault, violent crime, military service, or any other cause, taking place in Vancouver, Canada. …
Canada: Two More Subjects Treated
On June 26 and July 3, 2015, the fifth and sixth subjects were treated in our ongoing Canadian study of MDMA-assisted psychotherapy for PTSD. The sixth subject was enrolled on June 29. Led by Principal …
Canada: Fifth Subject Enrolled
On June 10, 2015, the fifth subject was enrolled in our ongoing Canadian study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Ingrid Pacey, M.D., in Vancouver, B.C., this Phase …
Canada: Fourth Subject Enrolled and Treated in Vancouver Study
On March 24, 2015, the fourth subject was treated in our ongoing Canadian study of MDMA-assisted psychotherapy for PTSD. This subject was enrolled on March 6, and treated by co-therapists Donna Dryer, …
Canada: Third Subject Treated in Vancouver Study
On March 14, 2015, the third subject received their first experimental treatment in our Canadian study of MDMA-assisted psychotherapy for PTSD. The second subject received their first treatment on Feb …
Canada: First Subject Treated in Vancouver Study
On February 3, 2015, the first subject received their first experimental treatment in our Canadian study of MDMA-assisted psychotherapy for PTSD. The purpose of this small Phase 2 study in up to 12 subjects …
Canada: First Preparatory Session; Second and Third Subjects Enrolled
In 2006—over eight years ago—MAPS begin working to start MDMA-assisted psychotherapy for PTSD research in Canada. Finally and after enormous effort, on January 2, 2015, the first preparatory psychotherapy …
Canada: First Subject Enrolled
On December 3, 2014, the first subject was enrolled in our Canadian study of MDMA-assisted psychotherapy for PTSD, led by Principal Investigator Ingrid Pacey, M.D., in Vancouver, BC. Goals for this study …
Canadian Study: Subject Screening Begins
On September 2, 2014, the first potential subjects were screened for our Canadian study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Ingrid Pacey, M.D., and co-therapists Donna …
Canadian Study: New Co-Investigators Participate in Therapist Training
From August 1-5, 2014, Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., led a two-and-a-half day training in Vancouver, BC, for the newly added co-investigators in our upcoming Canadian study of MDMA-assisted …